These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2066853)

  • 1. Effect of institutional differences on study of surfactant in two centers.
    Etches PC; Peliowski A; Finer NN; Tierney AJ
    J Pediatr; 1991 Jul; 119(1 Pt 1):162-3. PubMed ID: 2066853
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
    Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
    J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
    Corbet A; Bucciarelli R; Goldman S; Mammel M; Wold D; Long W
    J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
    J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
    Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
    J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surfactant therapy in newborns with hyaline membrane disease].
    Tsvetkova S; Chernookova V; Efremova R; Nedeva N; Bogdanova V
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():12-4. PubMed ID: 11188005
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing surfactant products.
    Prevost RR
    Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
    [No Abstract]   [Full Text] [Related]  

  • 10. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
    Narang A; Kumar P; Dutta S; Kumar R
    Indian Pediatr; 2001 Jun; 38(6):640-6. PubMed ID: 11418729
    [No Abstract]   [Full Text] [Related]  

  • 13. On surfactant replacement therapy with Exosurf.
    Courtney SE
    Pediatr Pulmonol; 1992 May; 13(1):60-1. PubMed ID: 1589317
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral blood flow velocity after surfactant instillation in preterm infants.
    van de Bor M; Ma EJ; Walther FJ
    J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962
    [No Abstract]   [Full Text] [Related]  

  • 15. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
    Bose C; Corbet A; Bose G; Prats JG; Russell L; Edwards K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S13-7. PubMed ID: 1735845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1990 Oct; 264(14):1802. PubMed ID: 2169534
    [No Abstract]   [Full Text] [Related]  

  • 18. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OSIRIS trial.
    Tarnow-Mordi W
    Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
    [No Abstract]   [Full Text] [Related]  

  • 20. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.